Johnson & Johnson (JNJ)
(Delayed Data from NYSE)
$147.08 USD
+0.66 (0.45%)
Updated Jun 7, 2024 04:00 PM ET
After-Market: $147.00 -0.08 (-0.05%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth F Momentum D VGM
Brokerage Reports
Johnson & Johnson [JNJ]
Reports for Purchase
Showing records 41 - 60 ( 499 total )
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
Optimized Entry and Exit Levels for JNJ 9123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
Optimized Entry and Exit Levels for JNJ 82123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
Optimized Entry and Exit Levels for JNJ 81123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
Optimized Entry and Exit Levels for JNJ 8123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
Optimized Entry and Exit Levels for JNJ 72123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
Weekly Retail Sales Tracker for Hem. Malignancies - Week Ended July 7
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
Optimized Entry and Exit Levels for JNJ 71123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
Optimized Entry and Exit Levels for JNJ 70723
Provider: Stock Traders Daily
Analyst: Research Department
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
Weekly Retail Sales Tracker for Solid Tumors - Week Ended June 30.
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
Optimized Entry and Exit Levels for JNJ 60123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
Weekly Retail Sales Tracker for Solid Tumors - Week Ended June 23.
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
Optimized Entry and Exit Levels for JNJ 062123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
Weekly Retail Sales Tracker for Solid Tumors - Week Ended June 9.
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
Optimized Entry and Exit Levels for JNJ 61123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
Optimized Entry and Exit Levels for JNJ 60123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
Optimized Entry and Exit Levels for JNJ 052123
Provider: Stock Traders Daily
Analyst: Research Department